Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK stocks end the week lower as slowdown woes mount

Fri, 15th Jul 2022 17:06

July 15 (Reuters) - London's FTSE 100 index ended the week lower on worries about aggressive interest rate hikes and a sharp slowdown in the global economy, even as energy and defensive stocks lifted the benchmark index more than 1% on Friday.

The FTSE 100 added 1.7%, supported by energy giant Shell, AstraZeneca and British American Tobacco . The domestically focussed FTSE 250 index gained 1.9%.

"Some of it is definitely down to investors buying the dip, and some of it is also down to the latest sort of update from the Fed," Danni Hewson, financial analyst at AJ Bell, said.

"Everybody is laser focussed on what the economy is going to look like six months down the line. Next week, the UK has its latest inflation figures out. I think those are going to look hot and that is going to rattle investors in the UK once again."

Bank of England (BoE) Deputy Governor Dave Ramsden said on Thursday interest rates very likely will have to go up further to stop a repeat of persistent inflation.

Investors were pricing a roughly 72.5% chance of the BoE announcing a rare half-percentage point hike on Aug. 4.

Global equities recouped some of their losses on Friday as investors tempered expectations of a more aggressive U.S. rate rise after upbeat retail sales data and comments from Federal Reserve policymakers, but sluggish economic growth in China due to widespread COVID-19 lockdowns continued to weigh on sentiment.

The lockdowns took a toll on London's luxury brand Burberry whose first-quarter comparable store sales rose just by 1%. The weakness in China pushed its shares 3.8% lower.

BT Group fell 7.7% to the bottom of FTSE 100 index, after media reports that peer Virgin Media O2 is in talks to buy broadband rival TalkTalk.

Tonic maker Fevertree fell 27.7% after it lowered its annual profit forecast, citing worsening cost pressures and logistical issues.

Aston Martin's shares surged 23.7% after the luxury carmaker brought Saudi Arabia's sovereign wealth fund as its second-largest shareholder and said it was looking to raise 653 million pounds ($771.58 million). (Reporting by Sruthi Shankar and Bansari Mayur Kamdar in Bengaluru; Editing by Sherry Jacob-Phillips, Arun Koyyur, William Maclean)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.